Hoplite Capital Management’s AbbVie ABBV Stock Holding History

Hoplite Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,573,047	Closed	-$93.2M	–	28
2015 Q4	$93.2M	Hold	1,573,047	–	–	4.04%	11
2015 Q3	$85.6M	Sell	1,573,047 -525,245	-25%	-$34.2M	3.24%	16
2015 Q2	$141M	Buy	2,098,292 +1,261,684	+151%	+$82.4M	3.77%	12
2015 Q1	$49M	Sell	836,608 -2,048,229	-71%	-$124M	1.51%	26
2014 Q4	$189M	Buy	2,884,837 +1,681,079	+140%	+$106M	5.23%	4
2014 Q3	$69.5M	Buy	+1,203,758	New	+$66.8M	1.77%	31

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hoplite Capital Management's ABBV Position: Q1 2016 in Review

Hoplite Capital Management sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 1,573,047 shares — an estimated $93.2M sold.

Hoplite Capital Management first reported a position in ABBV in Q3 2014 and held it in 6 quarters. The position peaked at $189M in Q4 2014. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Hoplite Capital Management reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
Hoplite Capital Management sold 1,573,047 AbbVie shares in Q1 2016, an estimated $93.2M.
Hoplite Capital Management first reported a position in AbbVie in Q3 2014 and held it in 6 quarters.
Hoplite Capital Management's AbbVie position peaked at $189M in Q4 2014.
1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Hoplite Capital Management's 13F filing for Q1 2016, filed 16 May 2016.